Find Academic Supervisors

Amit NairView profile

Assistant Professor

• Liver Transplantation
• Kidney Transplantation
• Pancreas Transplantation
• +3 more

Amit Nair is an Assistant Professor in the Department of Surgery, Transplant (SMD) at the University of Rochester Medical Faculty Group. He specializes in liver, kidney, and pancreas transplantation, with a focus on living donor transplants and hepatobiliary surgery. Liver Transplantation Kidney Transplantation Pancreas Transplantation Living Donor Transplantation Hepatobiliary Surgery Liver Cancer His research spans transplant surgery, hepatobiliary oncology, and minimally invasive techniques, including studies on DCD liver transplantation and socioeconomic disparities in cancer outcomes. Awards include the Young Investigator Award (2017) and Rays of Hope Research Grant (2011). Young Investigator Award (2017) Rays of Hope Research Grant (2011)

Kevin A. WalterView profile

Professor

• Neurosurgery
• Oncology
• Neuro-oncology
• +6 more

Dr. Kevin A. Walter is Chief of Neurosurgery at UR Medicine's Highland Hospital and a Professor of Neurosurgery and Oncology at the University of Rochester Medical Center. He holds joint appointments in the Department of Orthopaedics (SMD) and the Cancer Center. Dr. Walter earned his MD at Johns Hopkins University School of Medicine, completed neurosurgical residency and a neuro-oncology fellowship at Johns Hopkins, and served as Director of Adult Neuro-oncology at the University of Pittsburgh before joining Rochester in 2007. Dr. Walter's research focuses on experimental therapeutics for brain and spinal tumors, with a particular emphasis on improving patient survival and quality of life through clinical trials and laboratory investigations into tumor biology. His work spans glioblastoma, radiosurgery, and complex spinal interventions. His recent publications highlight advancements in dendritic cell vaccination for glioblastoma (2023), tumor treating fields (2020), and recurrence patterns post-chemoradiation. Earlier studies (2010-2007) explored vascular gene expression, spinal cord gliomas, and radiosurgery efficacy. NREF Young Investigator Award (2003) Blue Ribbon Presentation (2001) Hunterian Resident Neurosurgical Research Award (2001) Outstanding Presentation (2000) Hunterian Medical Student Neurosurgical Research Award (1995) Alpha Omega Alpha (1995) Dr. Walter conducts clinical research evaluating experimental therapies for brain and spinal cancers, including trials on dendritic cell vaccines and tumor treating fields. He also leads a research laboratory at the University of Rochester focused on novel tumor targets and drug delivery systems like biodegradable polymers.

• Biostatistics
• Survival Analysis
• Causal Inference
• +7 more

Marta Spreafico serves as Assistant Professor in Medical Statistics at Leiden University's Mathematical Institute and Researcher at the Leiden University Medical Center's Department of Biomedical Data Sciences. She is a core member of the Data Analysis and Survival for Personalised Oncology group and SIG Health Data Science initiative, driving translational research at the intersection of statistical methodology and pediatric oncology. Her educational foundation includes dual PhDs: a cum laude PhD in Mathematical Models and Methods in Engineering from Politecnico di Milano (2022) and a PhD in Mathematics from Leiden University (2022). She also holds an MSc (2018) and BSc (2015) in Mathematical Engineering from Politecnico di Milano, with thesis work focused on statistical modeling in heart failure and cancer contexts. PhD cum Laude, Mathematical Models and Methods in Engineering, Politecnico di Milano (2022) PhD, Mathematics, Leiden University (2022) MSc, Mathematical Engineering - Applied Statistics, Politecnico di Milano (2018) BSc, Mathematical Engineering, Politecnico di Milano (2015) Dr. Spreafico's research pioneers dual-track innovation: developing mathematically rigorous methodologies in survival analysis and causal inference while directly applying them to pediatric cancer treatment challenges. Her work specifically targets modeling chemotherapy-induced toxicity accumulation and dose-intensity effects in Ewing sarcoma and osteosarcoma, leveraging real-world cancer trial data and administrative databases to create personalized therapy prediction tools that account for time-varying clinical complexities. Her scientific recognition includes the Cum Laude PhD Award from Politecnico di Milano (2022) and a Bone Cancer Research Trust Skills Development Grant (2025). These honors reflect her methodological rigor and clinical impact in oncology statistics. As Principal Investigator of the €935k KWF-funded INDICATES project (2025-2028), she develops clinical prediction tools for Ewing sarcoma therapy individualization. Concurrently, she co-investigates the €546k KiKa-funded PACT-ES project advancing personalized chemotherapy approaches. She serves on MSc Graduation Committees for Mathematics and Statistics & Data Science at Leiden University, mentoring next-generation biostatisticians in cancer research methodologies. Her collaborative ecosystem spans the Data Analysis and Survival for Personalised Oncology group, SIG Health Data Science network, and Euro-Ewing Consortium partnerships. Through these frameworks, she integrates statistical innovation with clinical practice to transform pediatric cancer treatment paradigms using latent toxicity modeling and causal inference frameworks.

Alal EranView profile

Researcher

• Computational Biology
• Neurodevelopmental Disorders
• Genomics
• +5 more

Alal Eran is a computational biologist at Boston Children's Hospital, part of the Computational Health Informatics Program. Her research focuses on the molecular basis of neurodevelopmental disorders, particularly autism, integrating genomic and clinical data to understand gene-environment interactions. She investigates RNA-mediated regulation at synapses, A-to-I RNA editing levels, and mitochondrial RNA modifications influenced by environmental factors like UV exposure. Her work aims to improve early diagnosis and personalized care for children with autism. Key research areas include computational biology, precision medicine, and systems biology. She explores diagnostic biomarkers, disease comorbidities, and the impact of early infections and antibiotic use on neurodevelopmental outcomes. Her expertise spans bioinformatics tools for genomic analysis and clinical data integration, such as the i2b2 platform. Publications highlight her contributions to understanding autism subtypes, mitochondrial gene expression, and the sociocultural impacts of vaccines. She has also contributed to studies on inflammatory bowel disease (IBD) pathogenesis and racial disparities in pandemic outcomes. No scientific awards or advising activities are documented in the provided text. Labs/Teams: Member of the Computational Health Informatics Program at Boston Children's Hospital.

• Glycobiology
• Glycomics
• Biochemistry
• +2 more

Nicki Packer is Professor at Griffith University's Institute for Biomedicine and Glycomics. Her research expertise spans glycobiology, proteomics, and analytical chemistry with applications in cardiovascular disease, immunology, and metabolic disorders. Research focuses on: Glycan-protein interactions in immune regulation Glycan-based diagnostic tools Extracellular matrix biology Cardiovascular glycobiology Publications demonstrate methodological innovations in glycoanalytics (45%), glycoprotein functions (30%), and consortium reports (15%). Notable contributions include development of SSSMuG for multi-glycomic analysis and lectin-based SERS nanotags. She contributes to major collaborative initiatives including the HUPO Human Proteome Project and leads research on ASGR1 receptor's role in atherosclerosis.

Tonya KaltenbachView profile

Professor

• Gastroenterology
• Endoscopy
• Colorectal Cancer Screening
• +5 more

Tonya Kaltenbach, MD is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. She specializes in gastroenterology and endoscopy, with a focus on advancing endoscopic techniques, colonoscopy quality improvement, and medical education. Her work emphasizes simulation-based training, artificial intelligence integration in endoscopy, and colorectal cancer screening. Education: Dr. Kaltenbach earned her BA in Biologic Basis of Behavior from the University of Pennsylvania (1996), MD from Jefferson Medical College (2001), and completed residency at Stanford University (2004). She further specialized in gastroenterology at Stanford (2007) and holds an MSc in Clinical Research from UCSF (2007). Additional training includes advanced endoscopy fellowships in Japan (2009) and the US. Research: Her research spans endoscopy quality metrics, non-polypoid colorectal neoplasms, and improving adenoma detection rates. She leads initiatives like the VA Endoscopy Quality Improvement Program (VA-EQuIP) and pioneered simulation-based mastery learning for endoscopy training. Key contributions include advancing optical diagnosis techniques and AI applications in real-time polyp histology prediction. Awards: Recognized with the Distinguished Master Endoscopist award (ASGE, 2022), multiple Education Audiovisual Awards, and grants from institutions like the VA and NIH. Her work has been published in high-impact journals such as Gastroenterology and Annals of Internal Medicine . Grants & Teams: Collaborates on national projects like the VA-EQuIP trial and the Bali Endoscopy Simulation Training (BEST) program. Leads teams focusing on endoscopy training standards and colorectal cancer prevention strategies.

Aleksandar MilosavljevicView profile

Professor

• Genomics
• Cancer Genomics
• Bioinformatics
• +4 more

Aleksandar Milosavljevic is a Professor and holds the Henry and Emma Meyer Chair in Molecular Genetics at Baylor College of Medicine. He serves as Director of the Program in Quantitative & Computational Biosciences (QCB) and Co-Director of the Computational and Integrative Biomedical Research Center (CIBR). He is also a member of the Dan L Duncan Comprehensive Cancer Center. His research focuses on genomics, epigenomics, and bioinformatics, with a particular emphasis on cancer genomics, extracellular RNA communication, and clinical genome interpretation. Education: PhD from University of California, Santa Cruz (1990). Research interests include developing computational methods for analyzing genomic and epigenomic data, constructing biological atlases (e.g., Human Epigenome Atlas, exRNA Atlas), and advancing clinical genomic applications through projects like ClinGen. His work bridges basic science and translational medicine, with contributions to understanding tumor biology, genetic variant interpretation, and liquid biopsy technologies. Key projects include the NIH Roadmap Epigenomics Initiative, NIH Extracellular RNA Communication Consortium, and ClinGen, which developed tools like the Pathogenicity Calculator and Allele Registry. His lab collaborates widely, addressing challenges in structural genomics, stochastic epigenetic regulation, and precision medicine.

Renee A. BornemeierView profile

Professor

• Pediatric Cardiology
• Echocardiography
• Fetal Cardiology
• +3 more

Renee A. Bornemeier, M.D., is a Professor in the Department of Pediatrics at the University of Arkansas for Medical Sciences (UAMS), practicing at Arkansas Children’s Hospital since 1994. She currently serves as Director of the Bale Fetal Heart Center, specializing in pediatric and fetal echocardiography, cardiac anatomy, and 3D cardiac modeling. Her clinical expertise includes diagnosing and managing congenital heart defects, fetal complications, and valvular heart disease. Education and Training: Medical School: University of Arkansas for Medical Sciences Internship: Arkansas Children’s Hospital and University of Arkansas for Medical Sciences Residency: Arkansas Children’s Hospital and University of Arkansas for Medical Sciences Fellowship: Children’s Hospital of Philadelphia (Pediatric Cardiology) Research Focus: Her work emphasizes fetal tele-echocardiography, neonatal cerebral hemodynamics, and the application of 3D cardiac models. Key projects include evaluating a statewide fetal tele-echocardiography program and studying the impact of maternal cytokines on congenital heart defects. Labs/Teams: She leads the Bale Fetal Heart Center, integrating clinical care with research in fetal cardiac diagnostics and interventional cardiology. Her contributions include advancing remote fetal echocardiography networks across Arkansas.

Rose CairnsView profile

Senior Lecturer

• Clinical Toxicology
• Pharmacovigilance
• Toxicovigilance
• +7 more

Rose Cairns is a Senior Lecturer at the Sydney School of Pharmacy, University of Sydney, and Director of Research at the NSW Poisons Information Centre. Her career spans clinical toxicology, pharmaceutical policy, and poisoning prevention research since 2018. PhD in Pharmacy (2015), University of Sydney BPharm (Hons I + Medal) (2011), University of Sydney Rose specializes in clinical toxicology , pharmaceutical misuse , and poisoning epidemiology . Her research focuses on drug safety policy impacts, particularly after rescheduling events (codeine, alprazolam), and identifying at-risk populations for self-poisoning. Recent studies examine digoxin antidote supply-demand dynamics , melatonin use in youth , and poisoning trends in dementia patients . These utilize comprehensive data-linkage frameworks across Australian health systems. 2018 Sydney Children’s Hospitals Network Quality Award 2010 University Medal (Sydney) Multiple pharmaceutical society prizes She supervises research students studying over-the-counter medication poisonings, cancer drug utilization, and dementia-related exposure patterns. Rose contributes to the TOXINZ toxicology database and collaborates with international networks like EAPCCT and GTNet .

Gail CarsonView profile

Research Fellow

• Global Health Strategy
• Epidemiology
• Public Health Preparedness
• +3 more

Dr. Gail Carson is an Associate Fellow at Saïd Business School, University of Oxford, and serves as Director of the international clinical research network ISARIC. Her roles include Chair of WHO's GOARN partnership and Chair of the WHO EURO preparedness technical advisory group. She holds an OBE for her contributions to public health. Dr. Carson trained as an infectious diseases physician and has led pandemic preparedness and response efforts for over a decade. Her education includes a Diploma of Organisational Leadership from Saïd Business School (2017), which enhanced her interdisciplinary collaboration skills with sectors like sports and academia. She has extensive experience in global health networks, including managing the ISARIC federation of 130+ countries' clinical research sites and leading responses to outbreaks like Ebola and the SARS-CoV-2 pandemic. Research focuses on pandemic strategy, clinical data harmonization, and long-term health consequences of infectious diseases. Her work produced the ISARIC 4C Mortality Score and 4C Deterioration model for hospitalized patients. Key areas include global health equity, pandemic preparedness frameworks, and multi-stakeholder collaboration. Publications emphasize longitudinal cohort studies, systematic reviews, and predictive models for pandemic outcomes. Awards include the OBE (2021) recognizing her leadership in global health networks during crises. Advisory roles include directing ISARIC's 1M+ patient observational database and advising WHO on outbreak response strategies. She co-leads the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) and has pioneered ethical standards for emergency clinical trials in epidemics. Labs/Teams: ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium), GOARN (Global Outbreak Alert and Response Network), and WHO EURO Preparedness 2.0 Technical Advisory Group.

James GalaganView profile

Professor

• Biosensor Development
• Machine Learning
• Computational Biology
• +4 more

James Galagan is a Professor of Biomedical Engineering at Boston University, with affiliations in Electrical & Computer Engineering and the Bioinformatics Program. His primary appointment is in the Department of Biomedical Engineering. He holds roles as Associate Director of the Precision Diagnostics Center and leads the Galagan Lab, an interdisciplinary group focused on biosensor development, computational biology, and systems biology. Dr. Galagan's research integrates genomics, molecular biology, and electrical engineering to create wearable biosensors and study microbial systems. His work emphasizes high-throughput experimental methods and machine learning for analyzing genetic networks and metabolic pathways. Education includes a PhD in Computational Neuroscience from MIT and a B.S. in Computer and Electrical Engineering from UC Davis. His research spans microbial genetics, sensor technology, and genomic data analysis, with a focus on translating biological insights into practical diagnostic tools. Key projects include developing electrochemical biosensors for hormones and pathogens, and advancing databases like RegulonDB to map transcriptional regulation in bacteria. Publications highlight innovations in biosensor design, microbial gene regulation, and systems biology. His lab collaborates across disciplines to address challenges in diagnostics, environmental monitoring, and biomedical applications. Current efforts include refining wearable sensors and exploring the biophysical mechanisms underlying microbial signal processing.

• Congenital Heart Disease
• Pulmonary Vascular Disease
• Atherosclerosis
• +5 more

Professor David Celermajer is the Scandrett Professor of Cardiology at the University of Sydney’s Central Clinical School and Head of the Discipline of Cardiology. He holds roles as Academic Cardiologist at Royal Prince Alfred Hospital (RPAH), Director of Adult Congenital Heart Services, and Clinical Director of the Heart Research Institute. His academic affiliations include membership in the Sydney Environment Institute and Charles Perkins Centre. He is a Rhodes Scholar and University of Sydney Medallist, recognized with prestigious awards like the Blackburn Medal (2019) and Officer of the Order of Australia (AO). He serves on the editorial boards of leading cardiology journals and has published over 600 papers with an H-index of 110. Research focuses on congenital heart disease (CHD), pulmonary vascular disease, and atherosclerosis. Key projects include the ACHD Database at RPAH, exercise physiology in Fontan patients, and public health models for lifelong CHD care. He collaborates internationally with institutions in China, Finland, France, and the UK. Professor Celermajer advises over 25 PhD candidates and leads teams at the Heart Research Institute and RPAH. His clinical roles include directing Pulmonary Hypertension Services and serving on the Congenital Heart Alliance of Australia and New Zealand.

Shamkant NavatheView profile

Professor

• Data Modeling
• Database Design
• Data Integration
• +3 more

Shamkant Navathe - Professor of Computer Science Dr. Shamkant Navathe has been a faculty member at Georgia Tech's School of Computer Science since 1990. His research focuses on database systems, data integration, bioinformatics, and visualization. He currently serves as the Bioengineering PhD and MS Coordinator for the College of Computing. His affiliations include the School of Computer Science, Center for Bioinformatics and Computational Genomics, and Institute for People and Technology (IPaT). Key research areas include database modeling, data mining, and knowledge discovery. He has contributed to foundational textbooks like Fundamentals of Database Systems and pioneered work in semantic indexing, graph databases, and fairness in machine learning systems. His recent projects address challenges in smart mobility, disaster monitoring via social media, and healthcare analytics using physician notes. His publications span topics from data lake monitoring to clash resolution in construction, reflecting interdisciplinary collaboration. Though no awards are explicitly listed, his work has influenced both academic and industrial database practices globally. He advises on interdisciplinary projects involving bioinformatics and engineering design, though no specific students are listed here. His lab activities emphasize visualization tools (e.g., VIGOR), graph query systems, and declarative fairness frameworks like Omnifair.

• Head and Neck Cancer
• Human Papillomavirus (HPV) Vaccination
• Otolaryngology
• +5 more

Niels Kokot, MD is a Clinical Professor in the Department of Otolaryngology-Head & Neck Surgery at the Keck School of Medicine of USC , University of Southern California. His clinical and research focus spans head and neck oncology, HPV vaccination dynamics, reconstructive surgery, and health disparities in cancer survivorship. Role: Clinical Professor, Otolaryngology-Head & Neck Surgery Affiliation: Keck School of Medicine of USC Email: kokot@usc.edu Research Interests include head and neck cancer, HPV-related pathogenesis, reconstructive microsurgery, psychosocial determinants of postoperative outcomes, and health equity. He investigates disparities in cancer diagnosis, treatment of minority populations, and the role of digital platforms in patient education. Recent Publications highlight trends in cost-effectiveness of surveillance imaging, free flap outcomes, and the intersection of social media with health communication. His work spans clinical trials, systematic reviews, and epidemiological studies. Collaborations involve multidisciplinary teams, including critical care, endocrinology, and medical oncology. His career bridges basic science (notably cytokine signaling in the 1990s) with contemporary clinical and health systems research.

• Pediatric Critical Care
• Anesthesiology
• Respiratory Medicine
• +7 more

Patrick Allen Ross, MD, is a Clinical Professor of Anesthesiology at the University of Southern California (USC), affiliated with Children’s Hospital Los Angeles (CHLA). His research focuses on pediatric critical care, anesthesiology, and respiratory support, particularly in areas such as mechanical ventilation, post-extubation airway management, and outcomes of pediatric ICU patients. He has contributed significantly to understanding respiratory mechanics, ventilator weaning protocols, and the impact of hyperoxemia in critical care settings. His work includes studies on pediatric asthma management, parental involvement in analgesia decisions, and predictive modeling for cardiac outcomes post-terminal extubation. Ross has also explored innovations in drug delivery (e.g., vapor-phase epinephrine) and immunotherapeutic approaches involving CAR NK cells. Key research themes include ventilator-induced lung injury, non-invasive respiratory support techniques, and long-term airway morbidity. His publications emphasize translational research bridging clinical practice and mechanistic insights, often using animal models and large-scale healthcare databases.